NEW YORK – Beam Therapeutics on Tuesday disclosed initial clinical data, including one patient death, in a Phase I/II trial of its investigational sickle cell disease (SCD) gene-editing therapy ...
NEW YORK – Inify Laboratories on Tuesday said it has partnered with researchers at Karolinska Institutet to improve prostate cancer diagnosis through artificial intelligence-driven image analysis.
The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback